Cefotaxine / Sulbactum Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1gm+1gm, 500mg+500mg
Reference Brands: Various Indian Brand Available
Category:
Antibiotics
Cefotaxime + Sulbactam is used in the treatment of bacterial infections. Cefotaxime + Sulbactam is a combination of two medicines: Cefotaxime and Sulbactam. Cefotaxime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria.
Cefotaxine / Sulbactum Injection is available in Injection
and strengths such as 1gm+1gm, 500mg+500mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefotaxine / Sulbactum Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefotaxine / Sulbactum Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cefotaxime / Sulbactam Injection is a potent combination of a third-generation cephalosporin antibiotic and a beta-lactamase inhibitor, widely used for the treatment of serious bacterial infections. Cefotaxime works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while sulbactam protects cefotaxime from degradation by beta-lactamase enzymes, extending its spectrum of activity against resistant bacteria.
This injectable formulation is commonly prescribed for respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and bone and joint infections, particularly those caused by Gram-negative and certain Gram-positive organisms. The combination is effective in both hospital and outpatient settings where rapid antibacterial action is required.
Cefotaxime / Sulbactam Injection is administered via intravenous (IV) or intramuscular (IM) routes, allowing for precise dosing and rapid therapeutic effect. Its broad-spectrum activity, enhanced by sulbactam, makes it an essential tool in combating beta-lactamase-producing bacterial infections. Proper dosing, monitoring, and adherence to clinical guidelines ensure its safety and efficacy in managing severe and complicated infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing